About Queen Elizabeth II Medical Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Queen Elizabeth II Medical Centre
During the past decade, Queen Elizabeth II Medical Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer
2010-05-19
2017-12-13
Completed
152
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
2010-09-30
2015-06-30
Completed
210
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
2011-03-28
2012-11-16
Completed
160
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
2012-03-05
2016-07-20
Completed
402
Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223
2015-04-30
2016-01-22
Completed
185
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Medical Centre"
#1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Queen Elizabeth II Medical Centre
According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Medical Centre" are
"Contraception" (1 trials), "Erectile Dysfunction" (1 trials) and "Libido" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Medical Centre" in a lesser frequency.
Clinical Trials Intervention Types at Queen Elizabeth II Medical Centre
Most popular intervention types in "Queen Elizabeth II Medical Centre" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "EV/DNG (Qlaira, BAY86-5027, SH T00658ID)" (1 trials), "Microgynon" (1 trials) and "Vardenafil ODT (STAXYN, BAY38-9456)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Queen Elizabeth II Medical Centre
The vast majority of trials in "Queen Elizabeth II Medical Centre" are
1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Queen Elizabeth II Medical Centre
Currently, there are NaN active trials in "Queen Elizabeth II Medical Centre".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Queen Elizabeth II Medical Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth II Medical Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".